Study to Evaluate the Superior Efficacy of Cardiac Resynchronization (SyncAVTM) Using the SyncAVTM Algorithm

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

December 18, 2018

Primary Completion Date

October 27, 2021

Study Completion Date

October 27, 2021

Conditions
Heart Failure
Interventions
DEVICE

Abbott Medical® CRT device with SyncAVTM stimulation function

patients with Abbott Medical® CRT device will be randomized and SyncAVTM stimulation will be activated.

DEVICE

Abbott Medical® CRT device with biventricular stimulation (BiV)

patients with Abbott Medical® CRT device will be randomized and biventricular (BiV) stimulation will be activated.

Trial Locations (15)

11009

Hospital Universitario Puerta del Mar, Cadiz

17007

Hospital Universitario de Girona Dr. Josep Trueta, Girona

28040

Hospital Fundación Jimenez Díaz, Madrid

35016

Hospital Insular de las Palmas, Las Palmas de Gran Canaria

36312

Hospital Álvaro Cunqueriro, Pontevedra

39008

Hospital Universitario Marqués de Valdecilla, Santander

45071

Hospital Virgen de la Salud, Toledo

46014

Hospital General Universitario de Valencia, Valencia

46017

Hospital Universitario Dr. Peset, Valencia

47003

Hospital Universitario de Valladolid, Valladolid

48903

Hospital Universitario Cruces, Barakaldo

48960

Hospital Universitario de Galdakao, Galdakao

08916

Hospital Universitari Germans Trias i Pujol, Badalona

08907

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

08035

Hospital Universitario Vall d'Hebron, Barcelona

All Listed Sponsors
lead

Hospital Universitari Vall d'Hebron Research Institute

OTHER

NCT03961399 - Study to Evaluate the Superior Efficacy of Cardiac Resynchronization (SyncAVTM) Using the SyncAVTM Algorithm | Biotech Hunter | Biotech Hunter